Management of Resistant Hypertension in a 74-Year-Old Woman
This patient requires optimization of her current regimen by maximizing diuretic therapy and adding spironolactone as the fourth-line agent, while simultaneously ruling out pseudoresistance and secondary causes of hypertension. 1, 2
Confirm True Resistant Hypertension
This patient meets criteria for resistant hypertension: BP 158/86 mmHg on 5 medications (though her regimen needs optimization). However, you must first exclude pseudoresistance before intensifying therapy 1:
- Verify medication adherence - This is critical given her recent hypertensive crisis with vision changes 1
- Obtain home BP readings or 24-hour ambulatory monitoring to exclude white coat effect, especially given her recent hospital visit 1
- Ensure proper BP measurement technique - use appropriate cuff size, patient seated with back supported, feet flat on floor 1
Optimize Current Regimen Before Adding Agents
Her current regimen has significant problems that must be addressed 2, 3:
- She is on both metoprolol AND losartan - this dual RAS blockade provides no additional benefit and increases risk of hyperkalemia and acute kidney injury 4
- Replace HCTZ with a thiazide-like diuretic (chlorthalidone 12.5-25 mg daily) - thiazide-like diuretics are superior to HCTZ for resistant hypertension 2, 3
- Ensure maximum tolerated doses: amlodipine should be increased to 10 mg if tolerated 5
- Consider discontinuing metoprolol unless she has specific indications (heart failure, post-MI, atrial fibrillation) - beta-blockers are not first-line for resistant hypertension 2, 3
Add Mineralocorticoid Receptor Antagonist as Fourth-Line Agent
Spironolactone 25-50 mg daily is the most effective fourth-line agent for resistant hypertension 2, 3:
- The PATHWAY-2 trial demonstrated spironolactone is superior to other fourth-line options 2
- Monitor potassium and creatinine closely given her age and concurrent losartan use 4
- If spironolactone is contraindicated or not tolerated, alternatives include amiloride, doxazosin, or eplerenone 2
Screen for Secondary Causes
Given her severe hypertensive episode (196/107 mmHg) with vision changes, evaluate for 1:
- Obstructive sleep apnea - Ask about snoring, witnessed apnea, excessive daytime sleepiness 1
- Primary aldosteronism - Check aldosterone/renin ratio, especially before starting spironolactone 1
- Renal artery stenosis - Consider if she has known atherosclerotic disease (she's on clopidogrel, suggesting vascular disease) or worsening renal function 1
- Medication interference - Review for NSAIDs, decongestants, herbal supplements that can elevate BP 1
Assess for Target Organ Damage
Her recent vision changes warrant 1:
- Fundoscopic examination for hypertensive retinopathy 1
- Serum creatinine and urinalysis to assess for chronic kidney disease - if CKD is present, BP goal is <130/80 mmHg 1
- ECG to evaluate for left ventricular hypertrophy 1
Recommended Treatment Algorithm
- Verify adherence and obtain home BP monitoring 1
- Optimize to: Losartan 100 mg + Amlodipine 10 mg + Chlorthalidone 25 mg (discontinue metoprolol unless specifically indicated) 2, 3
- Add spironolactone 25 mg daily, titrate to 50 mg if needed after 4-6 weeks 2, 3
- Monitor potassium within 1 week of starting spironolactone, then monthly initially 4
- If BP remains uncontrolled after 3 months, consider adding a fifth agent (doxazosin, amiloride, or clonidine) 2, 3
Critical Caveats for This 74-Year-Old Patient
- Avoid excessive diastolic BP lowering - do not reduce diastolic BP below 60 mmHg, which increases cardiovascular risk in older adults 6
- Assess frailty and cognitive function - if she has moderate to severe frailty, less intensive BP targets may be appropriate 6, 7
- The recent vision changes are concerning - ensure ophthalmology follow-up to rule out hypertensive emergency sequelae, even though CT was negative 1
- Monitor for orthostatic hypotension given her age and polypharmacy - check standing BP at each visit 1, 6